Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program

✍ Scribed by van Pesch, Vincent; Bartholomé, Emmanuel; Bissay, Véronique; Bouquiaux, Olivier; Bureau, Michel; Caekebeke, Jo; Debruyne, Jan; Declercq, Inge; Decoo, Dany; Denayer, Pierre; De Smet, Eric; D’hooghe, Marie; Dubois, Bénédicte; Dupuis, Michel; Sankari, Souraya El; Geens, Karine; Guillaume, Daniel; van Landegem, William; Lysandropoulos, Andreas; de Noordhout, Alain Maertens; Medaer, Robert; Melin, Annick; Peeters, Katelijne; Ba, Rémy Phan; Retif, Cécile; Seeldrayers, Pierrette; Symons, Anoek; Urbain, Etienne; Vanderdonckt, Patrick; Van Ingelghem, Erwin; Vanopdenbosch, Ludo; Vanroose, Erwin; Van Wijmeersch, Bart; Willekens, Barbara; Willems, Christiana; Sindic, Christian

• Book ID: 125385874
• Publisher: Royal Association of Belgian Medical Scientific Societies
• Year: 2014
• Tongue: English
• Weight: 322 KB
• Volume: 114
• Category: Article
• ISSN: 0300-9009
• DOI: 10.1007/s13760-014-0308-9